Alignment Healthcare (ALHC)
(Delayed Data from NSDQ)
$7.82 USD
-0.03 (-0.38%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $7.84 +0.02 (0.26%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Income Statements
Fiscal Year end for Alignment Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,824 | 1,434 | 1,168 | 959 | 757 |
Cost Of Goods | 1,623 | 1,250 | 1,039 | 793 | 661 |
Gross Profit | 201 | 184 | 129 | 166 | 96 |
Selling & Adminstrative & Depr. & Amort Expenses | 329 | 313 | 307 | 172 | 125 |
Income After Depreciation & Amortization | -128 | -129 | -178 | -5 | -29 |
Non-Operating Income | 1 | -2 | 0 | -1 | 0 |
Interest Expense | 21 | 18 | 17 | 17 | 15 |
Pretax Income | -148 | -149 | -195 | -23 | -45 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -148 | -150 | -195 | -23 | -45 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -148 | -150 | -195 | -23 | -45 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -110 | -109 | -160 | 12 | -11 |
Depreciation & Amortization (Cash Flow) | 18 | 19 | 18 | 18 | 19 |
Income After Depreciation & Amortization | -128 | -129 | -178 | -5 | -29 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 186.22 | 181.21 | 171.96 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.79 | -0.83 | -1.14 | NA | NA |
Diluted Net EPS (GAAP) | -0.79 | -0.83 | -1.14 | -36.92 | NA |
Fiscal Year end for Alignment Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 628.60 | 465.39 | 456.71 | 462.38 | 439.16 |
Cost Of Goods | 573.22 | 417.76 | 397.88 | 410.64 | 396.32 |
Gross Profit | 55.38 | 47.63 | 58.83 | 51.73 | 42.84 |
SG&A, R&D, and Dept/Amort Expenses | 96.49 | 89.54 | 88.59 | 75.40 | 75.33 |
Income After SG&A, R&D, and Dept/Amort Expenses | -41.11 | -41.91 | -29.76 | -23.67 | -32.49 |
Non-Operating Income | -0.04 | 0.14 | 0.15 | 0.43 | 0.14 |
Interest Expense | 5.43 | 5.48 | 5.47 | 5.26 | 5.02 |
Pretax Income | -46.58 | -47.26 | -35.08 | -28.49 | -37.37 |
Income Taxes | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
Minority Interest | -0.05 | -0.02 | -0.03 | -0.02 | -0.09 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -46.58 | -47.23 | -35.08 | -28.49 | -37.37 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -46.52 | -47.21 | -35.05 | -28.48 | -37.28 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 189.01 | 188.33 | 187.33 | 185.99 | 183.11 |
Diluted EPS Before Non-Recurring Items | -0.25 | -0.25 | -0.19 | -0.15 | -0.20 |
Diluted Net EPS (GAAP) | -0.25 | -0.25 | -0.19 | -0.15 | -0.20 |